Bibhash Mukhopadhyay
Gründer bei Sound Bioventures Management, Inc.
Profil
Bibhash Mukhopadhyay has founded Sound Bioventures Management, Inc. in 2021 where he is currently the Managing Partner.
He has held former positions as Associate Director-Business Development at MedImmune LLC and Associate Director at AstraZeneca PLC from 2013 to 2015, Manager at Johnson & Johnson from 2010 to 2013, Principal at NEA Management Co. LLC from 2015 to 2020, Independent Director at PhaseBio Pharmaceuticals, Inc. from 2018 to 2020, and Director at Tarveda Therapeutics, Inc. He was also a Partner at Nan Fung Life Sciences.
Dr. Mukhopadhyay's education includes a doctorate from Baylor College of Medicine, a graduate degree from the University of Gottingen, and an undergraduate degree from All India Institute of Medical Sciences.
Aktive Positionen von Bibhash Mukhopadhyay
| Unternehmen | Position | Beginn |
|---|---|---|
| Sound Bioventures Management, Inc. | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von Bibhash Mukhopadhyay
| Unternehmen | Position | Ende |
|---|---|---|
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Private Equity Investor | 31.12.2020 |
| PHASEBIO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.02.2020 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 31.12.2015 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.09.2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.11.2013 |
Ausbildung von Bibhash Mukhopadhyay
| Baylor College of Medicine | Doctorate Degree |
| University of Gottingen | Graduate Degree |
| All India Institute of Medical Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Finance |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
| Sound Bioventures Management, Inc. | Finance |
